Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): what does the future hold?

We read with great interest the recent article by Pouletty et al,1 a multicentre cohort from Paris, which reported an increased incidence of Kawasaki disease (KD) like presentation in association with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection (Kawa-COVID-19) in children. It is considered as a part of (Paediatric inflammatory multisystem syndrome temporally associated (PIMS-TS) with SARS-CoV-2). The varied manifestations of PIMS-TS include KD-like illness, toxic shock syndrome and multisystem failure.2–4 There is a significant difference in epidemiology and diagnostic criteria used to identify this entity compared to the usual KD (non-COVID-19 related).2–4 The annual incidence of KD in Asian populations like Japan, and Pacific Islander descent was 260 per 100 000, but in the USA, it was 25 per 100 000 children.5 Though the initial epidemic of SARS-CoV-2 infection was prevalent in Asian...
Source: Annals of the Rheumatic Diseases - Category: Rheumatology Authors: Tags: ARD, COVID-19 Correspondence Source Type: research